Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Influenza
Meningococcal disease
NITAG documentation
2015
Clear all
Type of publications
NITAG documentation
(23)
SAGE documentation
(5)
Scientific publications
(2)
Systematic reviews (SYSVAC)
(20)
Topics
Background paper
(8)
Recommendation
(15)
Available to download in languages
English (EN)
(16)
French (FR)
(10)
Regions
Americas
(13)
Europe
(9)
Western Pacific
(1)
Countries
Diseases
Influenza
(14)
Meningococcal disease
(9)
Diphtheria
(1)
Haemophilus influenzae type B
(3)
Hepatitis A
(4)
Hepatitis B
(3)
Human papillomavirus (HPV)
(15)
Measles
(3)
Pertussis
(4)
Pneumococcal disease
(5)
Poliomyelitis
(1)
Rotavirus
(2)
Typhoid
(1)
Yellow fever
(4)
Vaccine topics
Target population
Publication date
2015
(23)
2024
(2)
2023
(8)
2022
(8)
2021
(5)
2020
(9)
2019
(26)
2018
(21)
2017
(12)
2016
(28)
2014
(28)
2013
(10)
2012
(3)
2011
(11)
2010
(27)
2009
(17)
2008
(3)
2007
(6)
2006
(7)
2005
(3)
2001
(1)
2000
(1)
1997
(1)
23 results found
2015
∙
ACIP, Lisa Grohskopf, Sonja Olsen, Joseph Bresee, Leslie Sokolow, Karen Broder, Ruth Karron
Prevention and Control of Influenza with Vaccines
2015
∙
Lisa Grohskopf, Sonja Olsen, Joseph Bresee, Leslie Sokolow
Prevention and Control of Seasonal Influenza with Vaccines
2015
∙
CFV
Prévention des infections graves dans les asplénies anatomiques ou fonctionnelles
2015
∙
Lisa Grohskopf
Proposed Recommendations2015-16 InfluenzaSeason
2015
∙
CFV
Recommandations de vaccination contre les méningo- coques pour les personnes à risque accru d’infection invasive et d’exposition : utilisation d’un vaccin quadri- valent conjugué également lors de rappels
2015
∙
Centre for Health Protection
Scientific Committee recommends priority groups to receive southern hemisphere influenza vaccine
2015
∙
Kathleen Coelingh
Update on Live Attenuated Influenza Vaccine (LAIV)
2015
∙
Brendan Flannery, Jessie Clippard
Updated interim influenza vaccine effectiveness estimates by age group and vaccine type for the 2014-15 season: Updates from the US Influenza Vaccine Effectiveness (Flu VE) Network
2015
Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults
2015
∙
Temitope Folaranmi, Lorry Rubin, Stacey W. Martin, Manisha Patel, Jessica MacNeil
Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register